BioReact

📍 Indianapolis, United States🗓 Founded 2023👥 7 employees💰 Last funded Oct 2025
Biotechnology Research🌐 bioreact.co
Website LinkedIn
BioReact is the AI and analytics layer powering modern bioprocess development. We help bioprocess teams manage, analyze, and optimize data from any bioreactor instrument, at any scale; from early R&D to pilot and manufacturing. BioReact automatically structures and aligns online signals, offline measurements, and experimental metadata into a single time-series framework, eliminating manual data wrangling and spreadsheet workflows. BioReact enables: - Unified data management across bioreactors, scales, and sites - Advanced visualization and statistical analysis to compare experiments, conditions, and outcomes in seconds - Predictive modeling and AI-driven optimization to recommend bioreactor conditions that improve yield, productivity, and process robustness Our AI models learn directly from historical bioprocess data, allowing teams to move beyond static DoE and intuition-driven experimentation toward adaptive, data-driven process optimization. BioReact is used across industrial biotech and biopharma to accelerate development timelines, reduce failed experiments, and unlock deeper insight into how cells behave under real process conditions.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BioReact?
BioReact has 1 investors on record on gritt.io, including 1 early-stage backers.
When did BioReact last raise funding?
The most recent investment in BioReact recorded on gritt.io was in October 2025.
When was BioReact founded?
BioReact was founded in 2023.
What industry is BioReact in?
BioReact operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioReact based?
BioReact is headquartered in Indianapolis, United States.